FIELD: biotechnology; medicine.
SUBSTANCE: use of a complex of A-I apolipoprotein whey protein with tetrahydrocortisol to stimulate the proliferative activity of bone marrow cells has been proposed.
EFFECT: invention can be used when cultivating bone marrow cells under conditions requiring the use of a serum-free medium, as well as in regenerative medicine to stimulate the proliferative activity of bone marrow cells in vivo in pathologies associated with impaired hematopoiesis, for example, in bone marrow failure syndrome or in case of blood loss that occurs after undergoing courses of chemotherapy or radiation therapy.
2 cl, 4 dwg, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
MEDIUM FOR CULTIVATING BONE MARROW CELLS INTENDED FOR CELLULAR THERAPY | 2020 |
|
RU2756926C1 |
MATERIALS AND METHOD FOR MODULATION OF PROLIFERATION AND DIFFERENTIATION OF REGULATORY, STEM AND OTHER SOMATIC CELLS | 2014 |
|
RU2620069C2 |
METHOD OF TREATING AND PREVENTING HYPERGLYCEMIA AND INSULIN RESISTANCE AND RELATED DISEASES AND FUNCTIONAL DISORDERS OF ORGANS AND SYSTEMS AND AGENT FOR ITS IMPLEMENTATION | 2023 |
|
RU2823334C1 |
METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
METADIHOL® - LIQUID AND GEL NANOLARTICAL PREPARATIONS | 2014 |
|
RU2631600C2 |
METHOD FOR STIMULATING ENDOGENOUS PRODUCTION OF CYTOKINES AND HEMOPOIETINS | 2012 |
|
RU2498821C1 |
MEDICATION POSSESSING IMMUNOSTIMULATING AND HEMOSTIMULATING ACTION | 2009 |
|
RU2414223C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
Authors
Dates
2024-01-18—Published
2023-02-03—Filed